Delivery Order SPE2DB20D2104-SPE2DB26FMBAR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,017.91 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award conditions. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025, and utilized firm fixed-price pricing with no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $30,692.41 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and carries firm fixed pricing with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,931.20 to supply 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract, awarded on September 26, 2025, with completion targeted for September 29, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,895.05 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract, executed on May 20, 2025, with completion by May 21, 2025, was issued under a firm fixed-price arrangement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,629.78 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a prescription anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, utilizing firm fixed-price pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $4,929.08 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. Issued on August 25, 2025, with an ultimate completion date of August 26, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $23,088.53 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. Performance will be conducted at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $95,172.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 26, 2025, with completion targeted for August 27, 2025. This competitive award, issued under firm fixed pricing terms, supports federal medical procurement needs through AmerisourceBergen's established supply chain. The contract specifies performance from the vendor's location in Conshohocken, Pennsylvania, where the company...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMBARDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,977.93 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The award was made on October 27, 2025, with an ultimate completion date of October 28, 2025, under firm fixed-price terms with no set-aside designation. The contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply pharmaceutical products and medical supplies globally to support military healthcare systems, including the Defense Health Agency and other federal healthcare programs. The company's federal pharmaceutical supply relationship with DLA demonstrates its critical role in supporting military medical readiness across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 10/27/25 |